Mammary gland hyperplasia
Conditions
Interventions
Control Group:Placebo patch Chinese medicine powder placebo acupoint application
Test Group:Detumescence analgesic paste Chinese medicine powder acupoint paste
Sponsors
Affiliated Hospital of Shandong University of Traditional Chinese medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Women aged between 18 and 45; 2. Meet the above diagnostic criteria of traditional Chinese Medicine and Western Medicine; 3. Participants who volunteered for the study did not take any other drug related to breast hyperplasia during treatment. 4. Informed Consent and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with Severe Menstrual Cycle Disorder; 2. Breast Inflammation, breast cancer; 3.3 months with a pregnancy plan; 4. And has the serious primary disease and so on serious heart brain blood vessel and liver kidney and hematopoiesis system; 5.3 months Oral Treatment Breast Disease Related Person; 6. Patients with other diseases requiring conventional treatment; 7. Pastes the place to have the skin wound, the ulcer, the skin infection or the scar constitution person and to the pastes allergic person. Note: The above items meet any 1 or more items should be excluded, can not be selected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Breast Pain (Vas Score);Detection of serum sex hormone level;Degree of nipple discharge;Size, hardness and distribution of breast masses;Clinical efficacy;Integral of TCM Syndrome;Integration of quality of life scale: SF-36 scale;Color doppler ultrasound of mammary gland; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver and kidney function;Ekg;CBC;Severity and incidence of adverse events;Vital signs T\P\R\BP;Urine routine;Stool routine; | — |
Countries
China
Contacts
Public ContactLiu Xiaofei
Outcome results
None listed